Pulse Biosciences Inc. PLSE stock is trading higher Friday, with session volume surging to about 1.68 million shares, far ...

TULSA, Okla. — A new procedure at the Oklahoma Heart Institute is changing lives for people at high risk for heart surgery.

Pulse Biosciences, Inc. (Nasdaq: PLSE), developer of the novel nPulse™ technology using proprietary Nanosecond Pulsed Field Ablation™ (nanosecond PFA or nsPFA™) energy, today announced late-breaking ...

Patrick Vellner talked about how it felt being awake during the heart ablation procedure and revealed how long the recovery ...

Learn about surgical options for hypertrophic cardiomyopathy (HCM), including septal myectomy, septal ablation, and heart ...

About LockeT Catheter Precision’s LockeT is a suture retention device intended to assist in wound closure after percutaneous venous punctures. LockeT is a Class 1 device registered with the FDA and ...

Heart patients in Rochester will soon benefit from a major investment in advanced cardiac care. Rochester General Hospital has reopened a fully renovated cardiac catheterization lab following a $1.5 ...

It’s still experimental but the pill helps rid the body of cholesterol in a way that today can be done only with injected ...

The price was down despite the company posting strong quarterly revenue and profit. The medtech company has major operations ...

Every February, Children's of Alabama in Birmingham recognizes the patients and families at its Pediatric and Congenital ...

Doctors at Oklahoma Heart Institute are now offering a newly FDA-approved heart valve replacement that requires no open-heart ...

A team from the CNIC and Hospital Clínico Universitario de Valladolid has developed a minimally invasive, catheter-based procedure to treat defective mechanical aortic valves ...